First Major Survey of Baby Boomer Attitudes on Alzheimer's Shows Fear About Their Own Future and Frustration Over Pace of New Drus Approvals Top Line Survey Results

ACT-AD is supported by a grant from: Elan Pharmaceuticals Medivation Pfizer Bristol-Myers Squibb Eisai JANSSEN AI Eli Lilly and Company Merck